132 related articles for article (PubMed ID: 1100948)
21. Multi-drug therapy in bacilliferous leprosy--two years experience.
Kaur S; Sharma VK; Kumar B; Singh M; Kaur I
Indian J Lepr; 1985; 57(3):483-90. PubMed ID: 3831085
[TBL] [Abstract][Full Text] [Related]
22. Clofazimine in pregnancy complicated by leprosy.
Farb H; West DP; Pedvis-Leftick A
Obstet Gynecol; 1982 Jan; 59(1):122-3. PubMed ID: 7078842
[TBL] [Abstract][Full Text] [Related]
23. Transformation from lepromatous to borderline leprosy under clofazimine therapy.
Mahapatra SB; Ramu G
Lepr India; 1976 Apr; 48(2):172-6. PubMed ID: 1022964
[TBL] [Abstract][Full Text] [Related]
24. Personal experience with clofazimine in the treatment of leprosy.
Azulay RD; da Silva NC; Zeo A; de Jesus M; Franca CB
Lepr Rev; 1975 Jun; 46(2 Suppl):99-103. PubMed ID: 1100972
[No Abstract] [Full Text] [Related]
25. Evaluation of multidrug therapy with rifampicin, clofazimine and D.D.S. in multibacillary leprosy cases.
Kundu SK; Hazra SK; Chaudhury S; Chatterjee B
Indian J Lepr; 1984; 56(1):78-85. PubMed ID: 6548246
[TBL] [Abstract][Full Text] [Related]
26. The antileprotic action of clofazimine (B663, G30, 320, Lamprene).
Azulay RD; da Silva NC; Zeo A; Portela AB; Franca JC; Peluso LL
Int J Lepr Other Mycobact Dis; 1974; 42(1):13-8. PubMed ID: 4607163
[No Abstract] [Full Text] [Related]
27. Chemotherapy of leprosy.
Biswas SK;
J Indian Med Assoc; 2004 Dec; 102(12):695-6, 698. PubMed ID: 15871354
[TBL] [Abstract][Full Text] [Related]
28. Experiences in treatment of histoid cases with clofazimine.
Theophilus S
Lepr India; 1976 Oct; 48(4 Suppl):713-7. PubMed ID: 1026808
[No Abstract] [Full Text] [Related]
29. Leprosy in the UK.
Bharucha T; Lockwood D
Br J Hosp Med (Lond); 2016 Oct; 77(10):C154-C156. PubMed ID: 27723400
[No Abstract] [Full Text] [Related]
30. Forty-four months' experience in the treatment of leprosy with clofazimine (Lamprene (Geigy)).
Schulz EJ
Lepr Rev; 1971 Sep; 42(3):178-87. PubMed ID: 5151819
[No Abstract] [Full Text] [Related]
31. The diagnosis and management of dapsone-resistant leprosy.
Waters MF
Lepr Rev; 1977 Jun; 48(2):95-105. PubMed ID: 331001
[No Abstract] [Full Text] [Related]
32. Impact of multidrug therapy on the treatment and control of leprosy.
Gilbody JS
Int J Lepr Other Mycobact Dis; 1991 Sep; 59(3):458-78. PubMed ID: 1890370
[No Abstract] [Full Text] [Related]
33. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
Chandorkar AG; Burte NP; Gade RK; Bulakh PM
Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
[TBL] [Abstract][Full Text] [Related]
34. Combined therapy in leprosy.
Gatti JC
Lepr Rev; 1975 Jun; 46(2 Suppl):155-60. PubMed ID: 1100955
[No Abstract] [Full Text] [Related]
35. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
Sapkota BR; Shrestha K; Pandey B; Walker SL
Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
[TBL] [Abstract][Full Text] [Related]
36. Clofazimine (Lamprene, B663) in the treatment of lepromatous leprosy in the United Kingdom. A 12 year review of 31 cases, 1966-1978.
Browne SG; Harman DJ; Waudby H; McDougall AC
Int J Lepr Other Mycobact Dis; 1981 Jun; 49(2):167-76. PubMed ID: 7196886
[TBL] [Abstract][Full Text] [Related]
37. Open trial with clofazimine in the management of recurrent lepra reaction and of sulphone sensitive cases: a preliminary report.
Ramanujam K; Iyer CG; Ramu G
Lepr Rev; 1975 Jun; 46(2 Suppl):117-20. PubMed ID: 1100950
[No Abstract] [Full Text] [Related]
38. Lepromatous leprosy: dapsone resistance.
Barrett DF
Proc R Soc Med; 1976 Jun; 69(6):391-2. PubMed ID: 959208
[No Abstract] [Full Text] [Related]
39. Follow up of BL/LL patients on a slightly modified WHO regimen of multidrug therapy.
Katoch K; Ramu G; Ramanathan U; Sengupta U; Sreevatsa
Indian J Lepr; 1987; 59(1):36-43. PubMed ID: 3611859
[TBL] [Abstract][Full Text] [Related]
40. Leprosy treatment during pregnancy and breastfeeding: A case report and brief review of literature.
Ozturk Z; Tatliparmak A
Dermatol Ther; 2017 Jan; 30(1):. PubMed ID: 27549245
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]